Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2022-03-31 00:00:00 ET · period of report 2022-03-31 · accession 0001209191-22-021875 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-31 | 2022-03-31 | ORIC | Piscitelli Dominic | CFO | P - Purchase | $5.36 | +60.0K | 60.0K | New | +$321.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | P | A | 60,000 | $5.36 | 60,000 | D | — | — | (F1) Represents the weighted average share price of an aggregate total of 60,000 shares purchased in the price range of $5.25 to $5.46 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |